Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
Yung‐Jue Bang; Eric Van Cutsem; A. Feyereislova; Hyun Cheol Chung; Lin Shen; Akira Sawaki; Florian Lordick; Atsushi Ohtsu · The Lancet · 2010
Acceso al recurso
Entrá al contenido desde la opción principal o elegí otra fuente disponible.
Página del recurso
Cómo citar
Elegí el formato que necesitás y copiá la referencia al portapapeles.
APA 7
Bang, Y, Cutsem, E. V, Feyereislova, A, Chung, H. C, Shen, L, Sawaki, A, Lordick, F, & Ohtsu, A. (2010). Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. https://doi.org/10.1016/s0140-6736(10)61121-x
MLA
Bang, Yung‐Jue, et al. "Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial." 2010. https://doi.org/10.1016/s0140-6736(10)61121-x.
Chicago
Bang, Yung‐Jue, Eric Van Cutsem, A. Feyereislova, Hyun Cheol Chung, Lin Shen, Akira Sawaki, Florian Lordick, and Atsushi Ohtsu. 2010. "Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.". https://doi.org/10.1016/s0140-6736(10)61121-x.
Harvard
Bang, Y. et al. 2010, Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial, The Lancet, available at: https://doi.org/10.1016/s0140-6736(10)61121-x [Accessed 2 Jul. 2026].
Detalles del recurso
Información bibliográfica útil para confirmar que se trata del material correcto.
- Título
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
- Autor / colaboradores
- Yung‐Jue Bang; Eric Van Cutsem; A. Feyereislova; Hyun Cheol Chung; Lin Shen; Akira Sawaki; Florian Lordick; Atsushi Ohtsu
- Editorial
- The Lancet
- Año de publicación
- 2010
- Idioma
- en
Materias
Explorá otros recursos relacionados a partir de estas materias.